21
May 2026
Mid-career surgeons show highest likelihood of leaving clinical practice
Surgeons are an integral part of the health care system, supplying critical and urgent care in nearly every field of medicine.
Stay Informed!
21
May 2026
Bioluminescent fungi reveal pathways for advanced biotechnology and medical applications
Like fireflies and many deep-sea creatures, certain fungi can naturally emit light through bioluminescence pathways in which specialized enzymes convert chemical energy into visible light.
21
May 2026
Universal free school meals linked to fewer student suspensions
A study published in Economic Inquiry provides new evidence that universal free school meals can meaningfully reduce out‐of‐school suspensions in both elementary and secondary schools.
21
May 2026
Study defines realistic performance goals for pediatric emergency departments
A large, multi-center study led by Ann & Robert H. Lurie Children's Hospital of Chicago derived "achievable benchmarks of care" (ABCs) using electronic health record data, which allows pediatric emergency departments across the country to set high yet realistic performance goals.
21
May 2026
Light-driven nanomotors improve multimodal breast cancer treatment efficacy
The nanomotor starts with bowl‑shaped mesoporous polydopamine (PDA) nanoparticles. These biocompatible bowls are loaded with two key payloads: Fe(II) ions as a Fenton catalyst, and BNN6, a thermally sensitive NO donor.
21
May 2026
Oral AD109 improves sleep apnea severity but tolerability remains a challenge
AD109, an investigational once-daily oral combination of aroxybutynin and atomoxetine, significantly improved airway obstruction and oxygenation in adults with mild-to-severe obstructive sleep apnea who could not use PAP therapy. However, symptom improvements did not clearly differ from placebo, and about one in five AD109 recipients discontinued treatment due to adverse events.
21
May 2026
Polymer-based immunotherapies enhance tumor targeting and immune activation
Conventional immune checkpoint inhibitors, such as anti-PD-1/PD-L1 and anti-CTLA-4 antibodies, can reinvigorate T cells but typically benefit less than 30% of patients.
21
May 2026
GLP-1 drugs may help curb addiction by targeting reward pathways
GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking behaviors through central reward and dopamine-related pathways. Most evidence remains preclinical, with limited early human data, so larger clinical trials are needed before these drugs can be recommended for addiction treatment.
20
May 2026
AI passed a classic Turing test by mastering the art of human small talk
In a standard three-party Turing test, persona-prompted LLMs were often judged to be human, with GPT-4.5 selected over real people 73% of the time in 5-minute trials. The findings suggest that short human-AI interactions now hinge less on factual intelligence and more on social style, conversational flow, and humanlike persona cues.
20
May 2026
Calcium and vitamin D supplements show limited fracture prevention benefits
Calcium, vitamin D, or combined supplements offer little to no clinically meaningful benefit on fracture and fall prevention in most older people, finds an in-depth review of the latest evidence published by The BMJ today.
